NCT01649999View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

281

Participants

Timeline

Start Date

March 1, 2012

Primary Completion Date

July 20, 2013

Study Completion Date

July 20, 2013

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

peficitinib

oral

DRUG

Placebo

oral

Trial Locations (7)

Unknown

Chugoku

Chūbu

Hokkaido

Kansai

Kantou

Kyushu

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY